Biosyent Inc
XTSX:RX

Watchlist Manager
Biosyent Inc Logo
Biosyent Inc
XTSX:RX
Watchlist
Price: 11.55 CAD -0.86%
Market Cap: 133.9m CAD
Have any thoughts about
Biosyent Inc?
Write Note

Biosyent Inc
Cash Taxes Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biosyent Inc
Cash Taxes Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Taxes Paid CAGR 3Y CAGR 5Y CAGR 10Y
Biosyent Inc
XTSX:RX
Cash Taxes Paid
CA$3m
CAGR 3-Years
24%
CAGR 5-Years
10%
CAGR 10-Years
11%
Bausch Health Companies Inc
TSX:BHC
Cash Taxes Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sundial Growers Inc
NASDAQ:SNDL
Cash Taxes Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Cash Taxes Paid
$621k
CAGR 3-Years
-11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Cash Taxes Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
Cash Taxes Paid
$81.4m
CAGR 3-Years
50%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Biosyent Inc
Glance View

Market Cap
133.9m CAD
Industry
Pharmaceuticals

BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. The company is headquartered in Mississauga, Ontario. BioSyent, through its wholly owned subsidiaries BioSyent Pharma Inc. (BioSyent Pharma) and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary of BioSyent, operates in the non-chemical insecticide business. BioSyent products include Combogesic, Aguettant System, Cathejell, Cysview, FeraMAX 150, FeraMAX Powder, Proktis-M, RepaGyn, and TIBELLA. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. Aguettant System are used for a variety of injectable medications in hospitals and the acute care setting. FeraMAX 150 is an oral hematinic indicated for the prevention and treatment of iron deficiency anemia. RepaGyn for the healing of the vaginal mucosa and the treatment of vaginal dryness.

RX Intrinsic Value
9.83 CAD
Overvaluation 15%
Intrinsic Value
Price

See Also

What is Biosyent Inc's Cash Taxes Paid?
Cash Taxes Paid
3m CAD

Based on the financial report for Sep 30, 2024, Biosyent Inc's Cash Taxes Paid amounts to 3m CAD.

What is Biosyent Inc's Cash Taxes Paid growth rate?
Cash Taxes Paid CAGR 10Y
11%

Over the last year, the Cash Taxes Paid growth was 120%. The average annual Cash Taxes Paid growth rates for Biosyent Inc have been 24% over the past three years , 10% over the past five years , and 11% over the past ten years .

Back to Top